EPTIS
BAM Logo

HLA-2C: Histocompatibility scheme - DQ2/DQ8

[HLA-2C HLA de susceptibilidad a enfermedad celiaca (HLA-DQ2/DQ8)]

EPTIS factsheet 135836 | Last revision 2015-11-07 | URL: https://www.eptis.bam.de/pts135836 https://www.eptis.bam.de/pts135836

PT provider
PT provider GECLID-SEI (External Quality for Diagnostic Immunology Laboratories under the auspices of the Spanish Society for Immunology) GECLID-SEI (External Quality for Diagnostic Immunology Laboratories under the auspices of the Spanish Society for Immunology)
Based in Spain
Language(s) Spanish/ English
Remarks We follow ISO 17043 & EFI guidelines.
Keywords
Product groups Human test material
Testing fields Medical analysis
Technical details
Test item Tested property Testing method
Human white blood cells Human leucocyte antigen HLA-DQ2/DQ8 Molecular typing
Aims of the PT scheme
Target group of participants
Linked to specific legislation / standards
Additional, subsidiary aims
Number of participants 30
Accredited or otherwise reviewed by a 3rd party
Operation is commissioned / requested by Spanish Society for Immunology
Fees and frequency
Participation fee 163 Euro
Regularly operated Yes (two times per year)
Year of first operation 2012
Contact details of the PT provider
Provider Contact person
GECLID-SEI (External Quality for Diagnostic Immunology Laboratories under the auspices of the Spanish Society for Immunology)
Pº de Filipinos s/n
47007 Valladolid
Spain

Phone: +34 983 41 88 23 Ext.89673
Fax:
Web: https://www.geclid.es https://www.geclid.es
Dr. Carmen Martin
Phone: +34 686 247 331
Fax:
Email: responsable@geclid.es responsable@geclid.es
If you find any mistakes please contact the responsible EPTIS coordinator in Spain, Mr Miquel Navarro. Mr Miquel Navarro.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.21